| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/21/2006 | EP1443915B1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 06/21/2006 | EP1438316B1 Phosphonic acid compounds as inhibitors of serine proteases |
| 06/21/2006 | EP1401415B1 Use of n-phenyl-2-pyrimidine-amine derivatives for treating inflammatory diseases |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |
| 06/21/2006 | EP1284952B1 Substituted chalcones as therapeutic compounds |
| 06/21/2006 | EP1244647B1 Quinazoline derivatives as vegf inhibitors |
| 06/21/2006 | EP1208092B1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 06/21/2006 | EP1200094B1 Ophthalmic compositions containing antibiotics and nsaids |
| 06/21/2006 | EP1189931B1 Peptide compounds that bind her2 |
| 06/21/2006 | EP1171133B1 R-hydroxynefazodone |
| 06/21/2006 | EP1140170B1 Antibody fragments for the topical treatment of ocular diseases |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | EP1025106B1 Allosteric adenosine receptor modulators |
| 06/21/2006 | EP0971601B1 Decaffeinated mate extracts and the use thereof |
| 06/21/2006 | EP0932626B1 G protein-coupled receptor antagonists |
| 06/21/2006 | CN1791575A Cyanofluoropyrrolidine derivative. |
| 06/21/2006 | CN1791425A C1 inhibitor with short half-life for transient treatment |
| 06/21/2006 | CN1791394A Preventive and/or therapeutic agent for inflammatory bowel disease |
| 06/21/2006 | CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 06/21/2006 | CN1788790A Extrasin beta-16 for promoting vascularization, tissue regeneration and wound healing |
| 06/21/2006 | CN1788789A Anti-inflammatory action of oxidation type extrasin beta-10 |
| 06/21/2006 | CN1788787A Plaster for orthopaedics and its preparation method |
| 06/21/2006 | CN1788771A Chinese medicinal preparation for treating traumatic injury and its preparation process |
| 06/21/2006 | CN1788769A Sumatra dragonsblood soft capsule and its preparation method |
| 06/21/2006 | CN1788740A Externally-used pain-relieving spray |
| 06/21/2006 | CN1788736A Inflammation-eliminating pain-easing spray and its preparation method |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives |
| 06/21/2006 | CN1260222C Antagonists of mcp-1 function and methods of use thereof |
| 06/21/2006 | CN1259949C Capsule for treating wound |
| 06/21/2006 | CN1259945C Antipyretic Chinese medicine preparation for child made of bupleurum root and cinnamon twig |
| 06/21/2006 | CN1259931C Soft capsule of forsythia fruit oil |
| 06/21/2006 | CN1259920C Biologically active agents and drugs |
| 06/21/2006 | CN1259908C Hydrolysis-optimized liplid emulsions and use thereof |
| 06/20/2006 | US7064229 Succinic acid derivatives |
| 06/20/2006 | US7064217 2-Aminoacetamide derivatives with hydroxy-, phosphonate-, and/or methylene phosphonate substituent; antitumor, anticoagulant, antiproliferative, and wound healing agents |
| 06/20/2006 | US7064204 Nitrogen compounds such as 4-(5-amino-7-phenethyl-7H-pyrazolo (4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-2-yl)-phenol, used as adenosine receptor antagonists, for prophylaxis of nervous, cardiovascular, respiratory, urogenital and immune disorders |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064147 Amino acids with affinity for the α-2-delta-protein |
| 06/20/2006 | US7064144 Imidazole derivatives as adenosine deaminase inhibitors |
| 06/20/2006 | US7064137 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 06/20/2006 | US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 06/20/2006 | US7064128 Preferentially substituted calcium channel blockers |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | US7064119 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 06/20/2006 | US7064115 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 06/20/2006 | US7064107 Prevention and reduction of blood loss |
| 06/20/2006 | US7063860 Bladder therapy; antiinflammatory agents |
| 06/20/2006 | US7063832 Treating musculoskeletal pain or restless leg syndrome by breathing a muscle relaxant condensation aerosol having a mass median aerodynamic diameter (MMAD) of <3 mu m and <5% relaxant degradation products; kits; heating a coating of drug on a support to vaporize and passing air through the heated vapors |
| 06/20/2006 | US7063831 Delivery of erectile dysfunction drugs through an inhalation route |
| 06/20/2006 | US7063830 condensation aerosol for delivery of lidocaine, verapamil, diltiazem, isometheptene and lisuride, wherein aerosol is formed by heating a thin layer containing the drug, on a solid support, to produce a vapor of the drug, and condensing the vapor to form aerosol |
| 06/20/2006 | CA2379585C Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| 06/20/2006 | CA2177392C Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 06/20/2006 | CA2135480C Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation |
| 06/15/2006 | WO2006063178A2 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof |
| 06/15/2006 | WO2006061642A1 Compounds |
| 06/15/2006 | WO2006060898A1 Method for treating inflammatory disorders |
| 06/15/2006 | WO2006042479A9 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 06/15/2006 | WO2006042103A3 Reversible inhibitors of cathepsin b |
| 06/15/2006 | WO2006015860A3 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 06/15/2006 | US20060128810 Remedies for allergic diseases |
| 06/15/2006 | US20060128809 Rapidly absorbed liquid compositions |
| 06/15/2006 | US20060128784 Bis-heteroaryl alkanes as therapeutic agents |
| 06/15/2006 | US20060128782 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions |
| 06/15/2006 | US20060128780 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 06/15/2006 | US20060128776 Opioid receptor active compounds |
| 06/15/2006 | US20060128768 Furanthiazole derivatives as heparanase inhibitors |
| 06/15/2006 | US20060128759 Substituted isoxazole derivatives and their use in pharmaceutics |
| 06/15/2006 | US20060128757 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 06/15/2006 | US20060128755 3'-trifluoromethyl-3,4,5,6-tetrahydro-2H-[1,2']-bipyridinyl-4-carboxylic acid (4-isopropylphenyl)amide; antiinflammatory and analgesic |
| 06/15/2006 | US20060128749 Compounds |
| 06/15/2006 | US20060128745 Chemical compounds |
| 06/15/2006 | US20060128734 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 06/15/2006 | US20060128732 enzyme inhibitor of phosphotidylinositol-3-kinase (PI3K); N-(7,8-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)nicotinamide; antiinflammatory agent, immunomodulators; asthma, dermatitis, rhinitis, allergic diseases, chronic obstructive pulmonary disease, rheumatoid arthritis, Graves' disease |
| 06/15/2006 | US20060128728 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors |
| 06/15/2006 | US20060128723 Sulptionamide compounds that modulate chemokine receptor activity (CCR4) |
| 06/15/2006 | US20060128717 Therapeutic agents useful for treating pain |
| 06/15/2006 | US20060128704 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists |
| 06/15/2006 | US20060128701 N-{4-[ethyl-(2-hydroxy-ethyl)-amino]-phenyl}-2-[4-(2-oxo-4H-benzo[d][1,3]oxazin-1- yl)-piperidin-1-yl]-acetamide; Eating disorders; CNS disorders; antidiabetic agents; psychological disorders; antiepileptic, antiinflammatory agents, autoimmune diseases; neuropeptide Y5 (NPY5) receptor antagonists |
| 06/15/2006 | US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 06/15/2006 | US20060128659 Sulfotransferase inhibitors |
| 06/15/2006 | US20060128655 Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents |
| 06/15/2006 | US20060128644 Use of mob-5 in pain |
| 06/15/2006 | US20060128629 Angiogenesis inhibitors, antitumor agents |
| 06/15/2006 | US20060128624 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 06/15/2006 | US20060127914 Nicotinic acetylcholine receptor |
| 06/15/2006 | US20060127894 Protein associated with cell growth, differentiation, and death |
| 06/15/2006 | US20060127508 Preparation for the relief of disease |
| 06/15/2006 | US20060127507 comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; treating neutropenia and aplastic anemia |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | US20060127400 Activation of regulatory T cells by alpha-melanocyte stimulating hormone |
| 06/15/2006 | US20060127378 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 06/15/2006 | US20060127357 Rapamycin and il-10 for the treatment of immune diseases |
| 06/15/2006 | US20060127319 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems |
| 06/15/2006 | CA2590711A1 Antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 06/15/2006 | CA2590585A1 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof |
| 06/14/2006 | EP1669462A1 Method of preparing alpha-glycosylisoquercitrin, intermediate therefor and by-product |
| 06/14/2006 | EP1669452A1 Promoter of synoviolin gene |
| 06/14/2006 | EP1669356A1 CCR1 Antagonists for the treatment of i.a demyelinating inflammatory disease |
| 06/14/2006 | EP1669082A1 Dried extract from inflammatory rabbit skin inoculated with vaccinia virus and process for its manufacture |